Benign lipomatous neoplasm of of intra-abdominal organs

CD2_BENIGN_LIPO_INTRATHO_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D17.5& Cause of death: ICD-10 — D17.5& 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D17
Name in latin: Neoplasma benignum lipomatosum organorum intra-abdominalium

NAME	CD2_BENIGN_LIPO_INTRATHO_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D175
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D175
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign lipomatous neoplasm of of intra-abdominal organs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign lipomatous neoplasm of of intra-abdominal organs

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	106	63	43
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	62.50	60.23	65.82

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
90: Matched controls
898

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D17.5

ICD-10 Finland

Benign lipomatous neoplasm of intra-abdominal organs

+∞

129.6

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

15.7

11.8

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

7.4

PJA12

NOMESCO Finland

Sentinel node biopsy

+∞

6.3

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

+∞

6.3

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

11.2

6.2

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030467) Casts [#/volume] in Urine by Automated count

221

3.02

7.08

3.2

2.7

1.1

0.6

e6/l

0.33

149

(3018095) Leukocytes [#/volume] in Urine

286

2.92

6.85

4.2

3.3

48.5

106.0

e6/l

0.82

193

(36304419) Bacteria [Presence] in Urine

212

2.84

6.19

3.5

2.5

—

(3023368) Bacteria identified in Blood by Culture

203

2.66

5.35

4.4

3.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

140

2.84

5.29

2.8

2.6

0.5

1.2

e6/l

2.11

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

127

2.90

5.26

2.9

1.7

3.3

e6/l

0.56

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

283

2.55

5.24

3.5

2.8

—

(3002582) Erythrocytes [#/volume] in Urine

243

2.58

5.24

3.4

2.8

21.4

339.9

e6/l

0.57

171

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

186

2.63

5.03

2.3

2.1

3.1

3.0

mg/l

0.08

160

(40768804) Tissue Pathology biopsy report

279

2.41

4.64

2.5

1.6

—

(3002256) Pathology report gross observation

3.19

4.39

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

341

2.27

4.16

4.4

3.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

194

2.39

4.13

3.3

3.5

—

(3026782) Osmolality of Urine

145

2.49

3.97

3.1

2.5

524.0

549.1

mosm/kgh2o

0.25

118

(3015736) pH of Urine

329

2.22

3.94

3.2

3.7

—

(3035350) Ketones [Presence] in Urine by Test strip

412

2.22

3.87

3.2

3.7

0.0

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

413

2.21

3.84

4.9

5.2

0.0

estimate

—

(3022145) Colonoscopy Study observation

2.85

3.82

1.6

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

417

2.17

3.70

3.3

3.7

0.0

estimate

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

101

875

4.27

3.57

18.8

11.8

33.6

21.5

mg/l

1.68

663

(40758558) Short blood count panel - Blood

183

2.26

3.51

6.4

4.9

—

(3044640) Blood type and Crossmatch panel - Blood

223

2.18

3.47

2.8

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

370

2.09

3.41

2.4

1.9

105.3

93.5

pmol/l

0.80

192

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

166

2.23

3.21

2.5

1.9

—

(3001604) Monocytes [#/volume] in Blood

404

1.96

2.90

5.4

4.7

0.6

e9/l

0.30

347

(3006315) Basophils [#/volume] in Blood

405

1.95

2.87

5.4

4.7

0.0

e9/l

0.11

348

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.20

2.78

6.5

—

(3000850) Epithelial cells [#/volume] in Urine

160

2.12

2.76

3.1

2.2

7.8

5.6

e6/l

0.24

138

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.88

2.74

1.3

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

448

1.92

2.73

8.5

6.2

4.1

4.2

e9/l

0.14

388

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

154

2.11

2.68

1.2

7.5

7.6

u/ml

0.00

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.41

2.59

1.4

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.26

2.46

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.35

2.46

1.5

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

160

2.02

2.41

1.3

1.2

10.1

34.1

iu/ml

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3.05

2.37

1.2

1.5

—

(1616796) Gas panel - Central venous blood

4.82

2.30

1.8

1.5

—

(3003694) ABO and Rh group [Type] in Blood

179

1.94

2.28

1.2

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.49

2.26

1.4

1.6

—

(42870588) Differential panel, method unspecified - Blood

272

1.83

2.25

4.8

4.9

—

(3044889) 12 lead EKG panel

631

1.89

2.19

3.8

3.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

558

1.82

2.19

5.3

4.0

—

385.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2.17

1.6

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

3.37

2.14

1.4

3.6

—

(3042936) Bacteria identified in Isolate by Culture

120

2.05

2.13

1.7

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2.41

2.12

2.9

2.0

46.3

61.1

ml/min/173m2

—

(3021589) Normoblasts [#/volume] in Blood

354

1.71

1.96

9.4

7.7

0.0

e9/l

0.00

282

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

180

1.84

1.93

1.9

1.6

0.7

1.1

mg/l

1.11

140

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.80

1.91

1.4

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.67

1.86

1.0

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

127

1.92

1.82

1.5

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

588

1.70

1.74

5.1

4.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

281

1.68

1.73

3.0

2.9

1716.9

1093.5

ng/l

0.43

229

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

498

1.65

1.72

3.1

3.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2.71

1.70

8.4

1.5

17.5

47.2

u/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2.15

1.68

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

3.12

1.60

1.3

1.1

—

(3012516) Albumin [Mass/volume] in Urine

295

1.64

1.60

3.3

3.0

38.6

57.9

mg/l

0.31

185

(40768797) Stomach Pathology biopsy report

125

1.85

1.58

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

110

1.89

1.56

1.4

1.5

—

(3032080) INR in Blood by Coagulation assay

317

1.60

1.51

7.5

9.4

1.4

inr

0.08

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.60

1.48

2.3

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

169

1.71

1.47

1.5

1.7

1147.5

1140.9

nmol/l

0.01

141

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.03

1.47

2.9

1.9

288.7

350.6

nmol/l

0.49

(3000991) Gas panel - Venous blood

2.13

1.44

7.2

6.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.30

1.41

7.1

6.3

94.2

93.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

100

926

2.41

1.40

23.2

13.9

79.8

77.9

umol/l

0.22

100

926

(3008898) HLA-B27 [Presence]

2.70

1.39

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2.02

1.28

6.1

4.3

86.8

83.7

ng/l

0.05

(3009542) Hematocrit [Volume Fraction] of Blood

785

1.71

1.25

21.9

13.0

37.8

40.1

1.32

559

(3002032) Base excess in Venous blood by calculation

1.84

1.23

3.5

3.6

0.5

2.6

mmol/l

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.10

1.21

1.4

1.1

—

(3012544) pH of Venous blood

1.82

1.19

3.5

3.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

313

1.51

1.18

3.8

3.7

5.9

8.6

mg/mmol

0.29

187

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

100

939

2.15

1.14

11.3

8.5

24.5

25.0

u/l

0.16

100

902

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.33

1.04

1.0

1.1

—

(4035726)

2.33

1.04

1.4

1.3

—

(40761511) CBC panel - Blood by Automated count

919

1.88

1.02

16.1

11.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.01

0.99

8.1

4.9

25.3

25.6

mmol/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

822

1.63

0.98

17.4

10.9

75.4

77.1

ml/min/173m2

0.32

655

(3052851) Hemolysis interference index of Serum or Plasma

2.29

0.95

5.3

4.0

—

(3049717) Cytology report of Urine Cyto stain

2.29

0.95

1.5

1.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.99

0.86

1.5

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.99

0.86

1.5

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.99

0.86

1.5

1.3

—

(3026008) Bacteria identified in Urine by Culture

257

1.41

0.83

4.5

3.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

109

0.52

0.77

6.0

4.6

39.7

31.3

—

(4034850)

1.85

0.74

15.3

10.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

119

1.51

0.72

5.7

2.3

0.8

mmol/l

0.07

108

(3000492) Spirometry study

1.66

0.71

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

359

1.33

0.69

5.0

3.7

36.9

33.0

ng/l

0.12

248

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.56

0.67

9.8

4.5

1.1

1.0

mmol/l

0.35

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.61

0.0

1.2

—

20.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

187

1.37

0.60

1.1

1.2

0.5

2.1

u/ml

—

(3022217) INR in Platelet poor plasma by Coagulation assay

126

1.42

0.56

20.6

20.7

—

1.4

—

(4010399)

1.54

0.56

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

165

1.34

0.50

5.0

4.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.49

0.48

1.4

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.49

0.48

1.9

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.49

0.48

2.9

2.1

0.7

0.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.43

0.46

2.9

2.0

0.8

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.46

0.44

2.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.41

0.0

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.41

0.0

1.2

—

(40768443) Skin Pathology biopsy report

1.49

0.41

1.6

1.4

—

(3019060) Gas panel - Arterial blood

1.34

0.40

3.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.35

0.39

1.4

—

(3000330) Specific gravity of Urine by Test strip

1.35

0.34

2.3

4.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

166

1.25

0.33

1.4

1.3

2.3

2.6

g/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.40

0.32

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

563

0.85

0.31

3.1

2.9

51.0

47.0

u/l

0.14

521

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

130

1.27

0.31

1.4

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.27

0.30

1.7

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.27

0.30

1.4

1.9

—

(36660697) Celiac disease serology panel - Serum

1.27

0.26

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

218

1.19

0.26

4.5

3.7

21.8

25.0

0.68

(3018677) aPTT in Platelet poor plasma by Coagulation assay

115

1.25

0.25

2.0

1.7

29.8

29.3

0.13

110

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.37

0.24

5.4

5.0

22.6

25.6

mmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.74

0.23

2.6

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.26

0.23

1.0

1.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.7

—

61.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

115

0.76

0.21

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

4.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.20

0.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

309

0.87

0.20

3.6

3.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.16

0.19

2.7

1.4

—

(3025941) Bacteria identified in Stool by Culture

1.16

0.19

2.2

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

855

1.17

0.19

3.9

4.3

1.3

mmol/l

0.12

775

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

332

1.13

0.18

3.6

3.8

—

(40761535) Cells panel - Urine sediment

1.12

0.16

2.4

2.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.79

0.16

2.8

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.81

0.14

4.1

7.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

281

0.90

0.13

1.9

2.0

207.6

161.7

u/l

0.34

259

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

154

1.12

0.11

3.2

2.6

0.9

0.8

ug/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.04

0.09

1.2

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

217

1.08

0.06

3.9

3.8

0.0

estimate

—

(3013512) EKG study

257

0.96

0.01

5.4

3.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

232

0.99

0.00

3.3

3.4

—

(44806420)

0.00

0.0

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.0

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

274.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

14.4

—

933.6

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

0.0

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.0

2.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

0.0

2.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

0.92

0.00

4.0

3.1

4.9

5.1

kpa

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

18.0

—

1803.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.0

1.2

—

9.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

6.2

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

0.97

0.00

3.7

2.9

—

(4146454)

0.00

0.0

2.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.89

0.00

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.96

0.00

3.6

2.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

2.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3004451) EKG impression Narrative

0.00

0.0

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.0

1.0

—

11.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

(21494755) Public health laboratory ask at order entry panel

0.93

0.00

1.3

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.2

—

(4027681)

0.00

0.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

0.0

2.3

—

11.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

11.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.4

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

5.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1.02

0.00

3.6

3.3

2.0

2.4

mmol/l

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.6

—

32.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

0.0

2.6

—

(4281824)

0.00

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

6.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIPO_INTRATHO_EXALLC – Benign lipomatous neoplasm of of intra-abdominal organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign lipomatous neoplasm of of intra-abdominal organs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints